Abstract
Background and aims: Autoreactive T cells are a hallmark of type 1
diabetes (T1D) pathogenesis and represent key mediators of islet autoimmunity.
Insulitic lesions from both T1D donors and NOD mice are
enriched with CD8+ Tcells which lead to beta-cell destruction. Previous
studies demonstrated that the human leukocyte antigen (HLA)-A2-restricted
zinc transporter 8 (ZnT8)186-194 beta-cell epitope is preferentially
targeted by interferon-γ-producing CD8+ T cells in T1D patients.
Although such autoimmune reactivity in T1D has been previously reported,
information is lacking about the pancreatic localization of such
ZnT8186-194-reactive CD8+ Tcell in T1D. Therefore, the aim of this study
was to identify ZnT8186-194-reactive cells in the pancreas of T1D donors
using HLA-A2 multimer (MMr) immunostaining.
Materials and methods: The in-situ MMr immunohistochemical detection
method used herein has been previously reported and validated. OCT
frozen pancreatic sections from n=4 T1D, n=4 islet-specific autoantibodies
positive (aAb+) and n=4 islet-specific autoantibodies negative
(CTR) non-diabetic donors were obtained from the nPOD network. PE
(Phycoerythrin)-coupled ZnT8186-194MMrs recognizing autoreactive
CD8+ T cells were loaded at 1μg/section and incubated at 4°C overnight.
Rabbit anti-PE and Goat anti-Rabbit-HRP were used in order to detect
MMr binding.
Results: We investigated whether ZnT8186-194-reactive cells were detected
in pancreata from nPOD donors. Sections from all 4 T1D cases analyzed
and from 2 of 4 aAb+ cases displayed ZnT8186-194 MMr+ cells,
while all sections from CTR cases were negative. ZnT8186-194 MMr+
cells were found scattered either within islets or the exocrine tissue.
MMr+ cell count per each section analyzed revealed an increased number
of positive cells in T1D cases and aAb+ cases compared with CTR;
moreover, an increased number of MMr+ cells were found in islets of
T1D cases compared with aAb+ donors. Parallel staining of sections with
control MMrs loaded with an irrelevant MelanA peptide did not detect
any positive cells, confirming ZnT8 specificity.
Conclusion: We detected for the first time the presence of ZnT8186-194-
reactive cells in the pancreas of T1D donors, thus suggesting an unprecedented
role for these cells in destructive insulitis during autoimmune diabetes
diabetes (T1D) pathogenesis and represent key mediators of islet autoimmunity.
Insulitic lesions from both T1D donors and NOD mice are
enriched with CD8+ Tcells which lead to beta-cell destruction. Previous
studies demonstrated that the human leukocyte antigen (HLA)-A2-restricted
zinc transporter 8 (ZnT8)186-194 beta-cell epitope is preferentially
targeted by interferon-γ-producing CD8+ T cells in T1D patients.
Although such autoimmune reactivity in T1D has been previously reported,
information is lacking about the pancreatic localization of such
ZnT8186-194-reactive CD8+ Tcell in T1D. Therefore, the aim of this study
was to identify ZnT8186-194-reactive cells in the pancreas of T1D donors
using HLA-A2 multimer (MMr) immunostaining.
Materials and methods: The in-situ MMr immunohistochemical detection
method used herein has been previously reported and validated. OCT
frozen pancreatic sections from n=4 T1D, n=4 islet-specific autoantibodies
positive (aAb+) and n=4 islet-specific autoantibodies negative
(CTR) non-diabetic donors were obtained from the nPOD network. PE
(Phycoerythrin)-coupled ZnT8186-194MMrs recognizing autoreactive
CD8+ T cells were loaded at 1μg/section and incubated at 4°C overnight.
Rabbit anti-PE and Goat anti-Rabbit-HRP were used in order to detect
MMr binding.
Results: We investigated whether ZnT8186-194-reactive cells were detected
in pancreata from nPOD donors. Sections from all 4 T1D cases analyzed
and from 2 of 4 aAb+ cases displayed ZnT8186-194 MMr+ cells,
while all sections from CTR cases were negative. ZnT8186-194 MMr+
cells were found scattered either within islets or the exocrine tissue.
MMr+ cell count per each section analyzed revealed an increased number
of positive cells in T1D cases and aAb+ cases compared with CTR;
moreover, an increased number of MMr+ cells were found in islets of
T1D cases compared with aAb+ donors. Parallel staining of sections with
control MMrs loaded with an irrelevant MelanA peptide did not detect
any positive cells, confirming ZnT8 specificity.
Conclusion: We detected for the first time the presence of ZnT8186-194-
reactive cells in the pancreas of T1D donors, thus suggesting an unprecedented
role for these cells in destructive insulitis during autoimmune diabetes
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetologia |
Vol/bind | 60 |
Udgave nummer | S1 |
Sider (fra-til) | S200-S201 |
ISSN | 0012-186X |
DOI | |
Status | Udgivet - 2017 |